Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy have?
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy has 245 citations in the OpenAlex counts ScholarIQ stores.
When was Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy published?
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy has 1999 year in the ScholarIQ index.
What is the open-access status of Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy?
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy has closed oa status in the ScholarIQ index.
What is the DOI of Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy?
The DOI for Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy is on the source record.
What is the PMID of Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy?
The PMID for Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy is on the source record.
What is the OpenAlex record for Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy?
The OpenAlex for Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy is on the source record.